PRAX

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company based in Cambridge, Massachusetts, focused on developing innovative therapies to address central nervous system disorders arising from neuronal imbalance. Leveraging a unique scientific platform, Praxis is advancing a robust pipeline of novel treatments tailored to conditions with significant unmet medical needs. The company is committed to improving patient outcomes and quality of life, positioning itself as a leader in the biopharmaceutical landscape dedicated to transformative solutions in neurology.